Literature DB >> 27883995

Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis.

Elwira Sieniawska1, Marta Swatko-Ossor, Rafał Sawicki, Krystyna Skalicka-Woźniak, Grazyna Ginalska.   

Abstract

OBJECTIVE: In this study, we aimed to describe the influence of natural terpenes on the antimycobacterial activity of first-line tuberculostatic drugs against isolated Mycobacterium tuberculosis.
MATERIALS AND METHODS: The natural terpenes used in this study were R-limonene, S-limonene, myrcene, sabinene, α-pinene, and β-elemene. The values of the minimum inhibitory concentration (MIC) for these terpenes, as well as for combinations of terpenes with tuberculostatic antibiotics (ethambutol, isoniazid, and rifampicin), were determined using a tube log2 dilution method in the range of 125-0.059 µg/mL.
RESULTS: S-limonene had a strong synergistic effect with all tested antibiotics (MIC decreased from 16 to 0.475 µg/mL for ethambutol, from 16 to 0.237 µg/mL for rifampicin, and from 32 to 0.475 µg/mL for isoniazid). Combinations of myrcene, R-limonene, β-elemene, and sabinene with tuberculostatic antibiotics resulted in a decreased MIC of the antibiotics (from 3.9 to 0.475 µg/mL for ethambutol, from 15 to 0.475 µg/mL for isoniazid, and from 0.475 to 0.237 µg/mL for rifampicin) while combinations of α-pinene with ethambutol and isoniazid resulted in increased MIC values (from 16 to 125 µg/mL for ethambutol, and from 32 to 125 µg/mL for isoniazid). Rifampicin had a synergistic increase in activity with all the tested compounds.
CONCLUSIONS: Our study showed that terpenes enhance the activity of tuberculostatic antibiotics.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27883995      PMCID: PMC5588368          DOI: 10.1159/000454680

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  20 in total

1.  Anti-tuberculosis drug resistance in strains of Mycobacterium tuberculosis isolated from patients in a tertiary hospital in Bahia.

Authors:  Eliana Dias Matos; Antônio Carlos Moreira Lemos; Carolina Bittencourt; Cristiane Leite Mesquita
Journal:  Braz J Infect Dis       Date:  2007-06       Impact factor: 1.949

Review 2.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

3.  Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates.

Authors:  Guilian Li; Jingrui Zhang; Qian Guo; Jianhao Wei; Yi Jiang; Xiuqin Zhao; Li-Li Zhao; Zhiguang Liu; Jianxin Lu; Kanglin Wan
Journal:  J Antibiot (Tokyo)       Date:  2015-02-18       Impact factor: 2.649

4.  Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.

Authors:  S Toungoussova; D A Caugant; P Sandven; A O Mariandyshev; G Bjune
Journal:  Int J Tuberc Lung Dis       Date:  2002-05       Impact factor: 2.373

5.  In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.

Authors:  Fa Ge; Fanli Zeng; Siguo Liu; Na Guo; Haiqing Ye; Yu Song; Junwen Fan; Xiuping Wu; Xuelin Wang; Xuming Deng; Qi Jin; Lu Yu
Journal:  J Med Microbiol       Date:  2010-01-14       Impact factor: 2.472

6.  Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.

Authors:  N Rastogi; K S Goh; L Horgen; W W Barrow
Journal:  FEMS Immunol Med Microbiol       Date:  1998-06

7.  Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.

Authors:  Diana Machado; Isabel Couto; João Perdigão; Liliana Rodrigues; Isabel Portugal; Pedro Baptista; Bruno Veigas; Leonard Amaral; Miguel Viveiros
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis.

Authors:  Sergio Andrade-Ochoa; Guadalupe Virginia Nevárez-Moorillón; Luvia E Sánchez-Torres; Manuel Villanueva-García; Blanca E Sánchez-Ramírez; Luz María Rodríguez-Valdez; Blanca E Rivera-Chavira
Journal:  BMC Complement Altern Med       Date:  2015-09-23       Impact factor: 3.659

9.  Evaluation of pulmonary and extrapulmonary tuberculosis in immunocompetent adults: a retrospective case series analysis.

Authors:  Selma Ates Guler; Fulsen Bozkus; Mehmet Fatih Inci; Omer Faruk Kokoglu; Hasan Ucmak; Sevinc Ozden; Murvet Yuksel
Journal:  Med Princ Pract       Date:  2014-10-17       Impact factor: 1.927

Review 10.  Essential oils in combination and their antimicrobial properties.

Authors:  Imaël Henri Nestor Bassolé; H Rodolfo Juliani
Journal:  Molecules       Date:  2012-04-02       Impact factor: 4.411

View more
  8 in total

Review 1.  A Medicinal Halophyte Ipomoea pes-caprae (Linn.) R. Br.: A Review of Its Botany, Traditional Uses, Phytochemistry, and Bioactivity.

Authors:  Ganiyu Akinniyi; Jeonghee Lee; Hiyoung Kim; Joon-Goo Lee; Inho Yang
Journal:  Mar Drugs       Date:  2022-05-17       Impact factor: 6.085

2.  Antibacterial Activity of Lactic Acid Producing Leuconostoc mesenteroides QZ1178 Against Pathogenic Gallibacterium anatis.

Authors:  Hua Zhang; HePing HuangFu; Xing Wang; ShanShan Zhao; Yuan Liu; Haoxin Lv; GuangYong Qin; Zhongfang Tan
Journal:  Front Vet Sci       Date:  2021-04-22

3.  Chemical Composition and Determination of the Antibacterial Activity of Essential Oils in Liquid and Vapor Phases Extracted from Two Different Southeast Asian Herbs-Houttuynia cordata (Saururaceae) and Persicaria odorata (Polygonaceae).

Authors:  Kristýna Řebíčková; Tomáš Bajer; David Šilha; Markéta Houdková; Karel Ventura; Petra Bajerová
Journal:  Molecules       Date:  2020-05-22       Impact factor: 4.411

Review 4.  Diversity, Ecology, and Prevalence of Antimicrobials in Nature.

Authors:  Megan M Mullis; Ian M Rambo; Brett J Baker; Brandi Kiel Reese
Journal:  Front Microbiol       Date:  2019-11-14       Impact factor: 5.640

5.  Enhancement of the antibiotic activity by quercetin against Staphylococcus aureus efflux pumps.

Authors:  Joycy F S Dos Santos; Saulo R Tintino; Ana R P da Silva; Cristina R Dos S Barbosa; Jackelyne R Scherf; Zildene de S Silveira; Thiago S de Freitas; Luiz J de Lacerda Neto; Luiz M Barros; Irwin Rose de A Menezes; Henrique D M Coutinho; José P Siqueira-Júnior; Francisco A B Cunha
Journal:  J Bioenerg Biomembr       Date:  2021-03-08       Impact factor: 2.945

6.  Antibacterial, antifungal and antioxidant activities of whole plant chemical constituents of Rumex abyssinicus.

Authors:  Irene Chinda Kengne; Léonel Donald Tsamo Feugap; Abdel Jélil Njouendou; Claudia Darille Jouogo Ngnokam; Mahamat Djamalladine Djamalladine; David Ngnokam; Laurence Voutquenne-Nazabadioko; Jean-De-Dieu Tamokou
Journal:  BMC Complement Med Ther       Date:  2021-06-05

7.  Nigella damascena L. Essential Oil-A Valuable Source of β-Elemene for Antimicrobial Testing.

Authors:  Elwira Sieniawska; Rafal Sawicki; Joanna Golus; Marta Swatko-Ossor; Grazyna Ginalska; Krystyna Skalicka-Wozniak
Journal:  Molecules       Date:  2018-01-28       Impact factor: 4.411

8.  The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains.

Authors:  Elwira Sieniawska; Rafal Sawicki; Marta Swatko-Ossor; Agnieszka Napiorkowska; Agata Przekora; Grazyna Ginalska; Ewa Augustynowicz-Kopec
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.